StockData
Stryker Corp logo

Stryker Corp (SYK) stock

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.00−3.08 (-0.98%)

Close on Nov 20, 2026Market cap $118.01BP/E 33.0Yield –

Stryker free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Stryker's free cash flow for the twelve months ending Sep 30, 2026 was $4.57B, up 12.3% year over year. For fiscal 2025 it was $4.28B, up 22.8% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $4.28B in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.28B+22.8%
FY2024Dec 31, 2024$3.49B+11.2%
FY2023Dec 31, 2023$3.14B+54.0%
FY2022Dec 31, 2022$2.04B-25.6%
FY2021Dec 31, 2021$2.74B-1.9%
FY2020Dec 31, 2020$2.79B+80.9%
FY2019Dec 31, 2019$1.54B-24.3%
FY2018Dec 31, 2018$2.04B+112.1%
FY2017Dec 31, 2017$961.00M-32.6%
FY2016Dec 31, 2016$1.43B+100.4%
FY2015Dec 31, 2015$711.00M-54.1%
FY2014Dec 31, 2014$1.55B-8.4%
FY2013Dec 31, 2013$1.69B+16.9%
FY2012Dec 31, 2012$1.45B+19.8%
FY2011Dec 31, 2011$1.21B-11.5%
FY2010Dec 31, 2010$1.37B+2.6%
FY2009Dec 31, 2009$1.33B+30.3%
FY2008Dec 31, 2008$1.02B+21.4%
FY2007Dec 31, 2007$840.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.22B-9.5%
Q2 FY2026Jun 30, 2026$1.06B+14.1%
Q1 FY2026Mar 31, 2026$415.00M+226.8%
Q4 FY2025Dec 31, 2025$1.88B+12.6%
Q3 FY2025Sep 30, 2025$1.35B+3.8%
Q2 FY2025Jun 30, 2025$928.00M+92.9%
Q1 FY2025Mar 31, 2025$127.00M+243.2%
Q4 FY2024Dec 31, 2024$1.67B+20.4%
Q3 FY2024Sep 30, 2024$1.30B+44.6%
Q2 FY2024Jun 30, 2024$481.00M-10.3%
Q1 FY2024Mar 31, 2024$37.00M-88.3%
Q4 FY2023Dec 31, 2023$1.38B+69.7%
Q3 FY2023Sep 30, 2023$902.00M+20.1%
Q2 FY2023Jun 30, 2023$536.00M+38.9%
Q1 FY2023Mar 31, 2023$315.00M+275.0%
Q4 FY2022Dec 31, 2022$815.00M+2.6%
Q3 FY2022Sep 30, 2022$751.00M-6.5%
Q2 FY2022Jun 30, 2022$386.00M-50.0%
Q1 FY2022Mar 31, 2022$84.00M-77.2%
Q4 FY2021Dec 31, 2021$794.00M-25.9%
Q3 FY2021Sep 30, 2021$803.00M+5.7%
Q2 FY2021Jun 30, 2021$772.00M+51.1%
Q1 FY2021Mar 31, 2021$369.00M-17.4%
Q4 FY2020Dec 31, 2020$1.07B+100.0%
Q3 FY2020Sep 30, 2020$760.00M+63.1%
Q2 FY2020Jun 30, 2020$511.00M+46.4%
Q1 FY2020Mar 31, 2020$447.00M+134.0%
Q4 FY2019Dec 31, 2019$536.00M-39.9%
Q3 FY2019Sep 30, 2019$466.00M-2.5%
Q2 FY2019Jun 30, 2019$349.00M-29.1%
Q1 FY2019Mar 31, 2019$191.00M+8.5%
Q4 FY2018Dec 31, 2018$892.00M+80.9%
Q3 FY2018Sep 30, 2018$478.00M–
Q2 FY2018Jun 30, 2018$492.00M-5.2%
Q1 FY2018Mar 31, 2018$176.00M+1366.7%
Q4 FY2017Dec 31, 2017$493.00M-4.3%
Q3 FY2017Sep 30, 2017-$63.00M–
Q2 FY2017Jun 30, 2017$519.00M–
Q1 FY2017Mar 31, 2017$12.00M–
Q4 FY2016Dec 31, 2016$515.00M–

More Stryker figures

See a number that looks wrong?